Scholarlink

<p>Premenstrual dysphoric disorder (PMDD) is a gynecologically relevant illness and typical features are predominantly severe emotional and sometimes physical symptoms that occur in the luteal phase. The PMDD is the most severe form of the premenstrual syndrome (PMS). As approximately 3–8% of women in childbearing age are affected, it represents an important challenge in gynecological practices. The PMDD is still a little known, underdiagnosed and insufficiently treated disorder. This article provides an overview of the symptoms (as demarcation from PMS) and the diagnostic criteria of PMDD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and the International Statistical Classification of Diseases and Related Health Problems (ICD-11). It illuminates evidence-based treatment approaches, which encompass hormone therapy, the use of certain antidepressant agents and psychotherapeutic procedures. Even if the etiology is not yet completely clarified, there are effective treatment approaches. An interdisciplinary approach is recommended for the successful treatment of this disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prämenstruelle dysphorische Störung – gynäkologische Diagnostik und Therapie im interdisziplinären Kontext

  • 期刊论文

  • 发表日期：

    2025年1月9日

查看全文
  • Almut Dorn,
  • Anke Rohde,
  • Anneliese Schwenkhagen

摘要

Premenstrual dysphoric disorder (PMDD) is a gynecologically relevant illness and typical features are predominantly severe emotional and sometimes physical symptoms that occur in the luteal phase. The PMDD is the most severe form of the premenstrual syndrome (PMS). As approximately 3–8% of women in childbearing age are affected, it represents an important challenge in gynecological practices. The PMDD is still a little known, underdiagnosed and insufficiently treated disorder. This article provides an overview of the symptoms (as demarcation from PMS) and the diagnostic criteria of PMDD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and the International Statistical Classification of Diseases and Related Health Problems (ICD-11). It illuminates evidence-based treatment approaches, which encompass hormone therapy, the use of certain antidepressant agents and psychotherapeutic procedures. Even if the etiology is not yet completely clarified, there are effective treatment approaches. An interdisciplinary approach is recommended for the successful treatment of this disease.